Evidence map›Paper›PMID 39560665›Full record

ArticleThe Journal of experimental medicine2024

Selective regulation of IFN-γ and IL-4 co-producing unconventional T cells by purinergic signaling.

Calvin Xu, Andreas Obers, Minyi Qin, Alice Brandli, Joelyn Wong, Xin Huang, Allison Clatch, Aly Fayed, Graham Starkey, Rohit D'Costa and 7 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Mechanisms and Applications of γδ T Cells in Anti-Tumor Immunity.Cancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Calvin XuDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0003-0753-7639
Andreas ObersDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0009-0005-8768-0153
Minyi QinDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0009-0005-9404-3662
Alice BrandliDepartment of Anatomy and Physiology, The University of Melbourne, Melbourne, Australia.ORCID 0000-0002-4842-3438
Joelyn WongThe Florey Institute of Neuroscience and Mental Health , Melbourne, Australia.ORCID 0000-0001-7541-0715
Xin HuangThe Florey Institute of Neuroscience and Mental Health , Melbourne, Australia.ORCID 0000-0002-7278-3070
Allison ClatchDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0009-0007-5436-7608
Aly FayedLiver and Intestinal Transplant Unit, Austin Health , Melbourne, Australia.ORCID 0000-0001-6076-8140
Graham StarkeyLiver and Intestinal Transplant Unit, Austin Health , Melbourne, Australia.ORCID 0000-0002-4285-1343
Rohit D'CostaDonateLife Victoria , Carlton, Australia.ORCID 0000-0003-2313-2623
Claire L GordonDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0001-5172-4728
Jeffrey Y W MakCentre for Chemistry and Drug Discovery, Institute for Molecular Bioscience, University of Queensland , Brisbane, Australia.ORCID 0000-0002-8011-4539
David P FairlieCentre for Chemistry and Drug Discovery, Institute for Molecular Bioscience, University of Queensland , Brisbane, Australia.ORCID 0000-0002-7856-8566
Lynette BeattieDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0002-5794-7233
Laura K MackayDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0002-8496-6632
Dale I Godfrey *Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0002-3009-5472
Hui-Fern Koay *Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0002-3236-9609

Funding

Australian Postgraduate AwardAustralian Research Council DE220100830National Health and Medical Research Council 1140126NIH HHS RO1 AI14807-01A1Sylvia and Charles Viertel Charitable Foundation
6 · The paper itself

Abstract

Unconventional T cells, including mucosal-associated invariant T (MAIT), natural killer T (NKT), and gamma-delta T (γδT) cells, comprise distinct T-bet+, IFN-γ+ and RORγt+, IL-17+ subsets which play differential roles in health and disease. NKT1 cells are susceptible to ARTC2-mediated P2X7 receptor (P2RX7) activation, but the effects on other unconventional T-cell types are unknown. Here, we show that MAIT, γδT, and NKT cells express P2RX7 and are sensitive to P2RX7-mediated cell death. Mouse peripheral T-bet+ MAIT1, γδT1, and NKT1 cells, especially in liver, co-express ARTC2 and P2RX7. These markers could be further upregulated upon exposure to retinoic acid. Blocking ARTC2 or inhibiting P2RX7 protected MAIT1, γδT1, and NKT1 cells from cell death, enhanced their survival in vivo, and increased the number of IFN-γ-secreting cells without affecting IL-17 production. Importantly, this revealed the existence of IFN-γ and IL-4 co-producing unconventional T-cell populations normally lost upon isolation due to ARTC2/P2RX7-induced death. Administering extracellular NAD in vivo activated this pathway, depleting P2RX7-sensitive unconventional T cells. Our study reveals ARTC2/P2RX7 as a common regulatory axis modulating the unconventional T-cell compartment, affecting the viability of IFN-γ- and IL-4-producing T cells, offering important insights to facilitate future studies into how these cells can be regulated in health and disease.

Indexed as

Interferon-gammaInterleukin-4Mice, Inbred C57BLMucosal-Associated Invariant T CellsReceptors, Purinergic P2X7Signal TransductionAnimalsMiceNatural Killer T-CellsReceptors, Antigen, T-Cell, gamma-deltaIFNG protein, mouseIl4 protein, mouseInterferon-gammaInterleukin-4P2rx7 protein, mouseReceptors, Antigen, T-Cell, gamma-deltaReceptors, Purinergic P2X7

Identifiers

PMID39560665
PMCPMC11577439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.